Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps

The introduction of a new Group A meningococcal conjugate vaccine, MenAfriVacR, has been a important public health success. Group A meningococcal meningitis has disappeared in all countries where the new Men A conjugate vaccine has been used at public health scale. However, continued control of Grou...

Full description

Bibliographic Details
Main Authors: F. Marc LaForce, Mamoudou Djingarey, Simonetta Viviani, Marie-Pierre Preziosi
Format: Article
Language:English
Published: Taylor & Francis Group 2018-05-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2017.1378841